Amgen's Total Assets for the quarter that ended in Dec. 2023 was HK$758,753 Mil.
Warning Sign:
If a company builds assets at 13.8% a year, faster than its revenue growth rate of 8% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Amgen's average Total Assets Growth Rate was 54.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 18.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 13.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 5.50% per year.
During the past 13 years, Amgen's highest 3-Year average Total Assets Growth Rate was 93.20%. The lowest was -5.40%. And the median was 12.70%.
Total Assets is connected with ROA %. Amgen's annualizedROA % for the quarter that ended in Dec. 2023 was 3.27%. Total Assets is also linked to Revenue through Asset Turnover. Amgen's Asset Turnover for the quarter that ended in Dec. 2023 was 0.09.
Amgen Total Assets Historical Data
The historical data trend for Amgen's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Amgen's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Amgen's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Amgen Total Assets Related Terms
Thank you for viewing the detailed overview of Amgen's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:04332 has been successfully added to your 